Windward Bio Group Ag (NASDAQ:WWB)
| Market Cap | $361.94M-17.8% |
| Revenue (ttm) | n/a |
| Net Income | n/a |
| EPS | n/a |
| Shares Out | 15.44M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 89,411.491 |
| Open | $25.00 |
| Previous Close | $28.50 |
| Day's Range | $22.49 - $25.60 |
| 52-Week Range | $18.35 - $33.99 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About WWB
Operates as a holding company whose subsidiaries develops and commercializes therapeutics
$WWB stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in WWB holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by WWB's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
WWB Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New WWB patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to WWB from public contracts
Source: USAspending.gov
Bull Case vs Bear Case
AI-generated from WWB’s recent data — informational, not investment advice
What’s Behind the Score
News check: IPO milestone with strong share price movement; concrete business event outweighs speculative analysis pieces.
Recent Insider Activity
No Form 4 filings in the last 90 days.
